Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
卵巢组织冷冻保存的优化方案和基于 modRNA 的新型方法可改善慢性病女孩生育力保存的移植结果
基本信息
- 批准号:10458028
- 负责人:
- 金额:$ 25.93万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-29 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAdolescentAdultAdverse effectsAffectAnimal ModelAttentionAutologous TransplantationCancer PatientChildChildhoodChronicChronic DiseaseClinicalCryopreservationDevelopmentDiagnosisDiseaseDisease remissionEmbryoEndocrineEnvironmentFDA approvedFemaleFertilityFormulationFoundationsFreezingGerm CellsGoalsGonadal structureGraft SurvivalHealthHumanInfertilityInflammatoryLive BirthLongevityMacacaMacaca mulattaMalignant NeoplasmsMessenger RNAMethodologyMethodsModalityMolecularOocytesOrgan DonorOutcomeOutputOvarianOvarian FollicleOvarian TissueOvarian tissue cryopreservationOvariectomyPathologyPatient RepresentativePatientsPhasePremature MenopausePrimordial FollicleProceduresProductionProductivityProtocols documentationQuality of lifeRecombinantsRecoveryRhesusSiteSliceStandardizationSurvival RateSystemTestingTherapeuticThinnessTissue SurvivalTissue TransplantationTissuesTransplantationVEGFA geneWorkXenograft procedurebasechemotherapyexperimental studyfertility preservationgirlshuman tissueimprovedmullerian-inhibiting hormonenovelovarian reserveovary transplantationpatient populationpersonalized diagnosticspost-transplantpre-clinicalprepubertypreservationreproductivesuccessyoung adult
项目摘要
Project Summary
With increased diagnostic precision and expanded treatment options, the health and lifespan of children
born with chronic diseases has extended significantly into adulthood, drawing attention to preserving their
quality of life and reproductive options. Unfortunately, the pathology of many chronic conditions can have
negative consequences for the gonad, resulting in infertility and/or premature menopause.
Cryopreservation (and later auto-transplantation) of whole ovarian tissue could provide a means of “safe-
guarding” ovarian reserve from the gonadotoxic effects of disease pathology, and this approach has been
utilized in cancer patients to yield at least 100 live births since early attempts more than a decade ago.
Although this approach is effective, the viability and productivity of cryopreserved ovarian tissue is
drastically undermined by the inflammatory, ischemic environment within the graft during the acute phase
post-transplant.
This proposal leverages the potent bioactivity and straightforward delivery of modified mRNA
(modRNA) as a therapeutic approach to improving the viability and output of ovarian tissue autografts.
Using a xenograft platform developed by our group, we will investigate the potential for modRNA to: 1)
improve viability and output of ovarian tissue transplanted for the purpose of fertility preservation; 2)
maintain a robust pool of ovarian follicles in a quiescent primordial state that will serve as a long-term
reservoir for normalization of endocrine function and oocyte output; and 3) demonstrate the efficacy of this
approach in a highly relevant pre-clinical animal model, rhesus macaque. With these experiments we will
establish a foundation for robust, repeatable and FDA-approvable methods for ovarian tissue
cryopreservation/auto-transplantation in chronically diseased girls that wish to maintain their reproductive
options.
项目摘要
随着诊断精度和扩大治疗方案的提高,儿童的健康和寿命
出生于慢性疾病已经大大扩展到成年,引起人们的注意
生活质量和生殖选择。不幸的是,许多慢性病的病理可能会有
性腺的负面后果,导致不育症和/或更年期。
整个卵巢组织的冷冻保存(后来的自动转移)可以提供“安全”
保护“卵巢储备免受疾病病理的性腺毒性作用,这种方法一直是
自十多年前早期尝试以来,在癌症患者中使用至少100个活产。
尽管这种方法是有效的,但是冷冻保存卵巢组织的生存能力和生产力是
急性期在移植物内部炎症性的缺血环境大为破坏
移植后。
该提案利用了修改的mRNA的潜在生物活性和直接递送
(ModRNA)作为改善卵巢组织自体移植的生存能力和输出的治疗方法。
使用我们小组开发的异种移植平台,我们将研究ModRNA的潜力:1)
改善移植的卵巢组织的活力和输出,以保存生育; 2)
将坚固的卵巢卵泡池保持在静止的原始状态,该状态将作为长期
用于内分泌功能和卵母细胞输出的归一化库; 3)证明这一点的效率
在高度相关的临床前动物模型恒河猴中的方法。通过这些实验,我们将
为卵巢组织的可靠,可重复和FDA批准的方法建立基础
渴望维持其生殖的长期宣告的女孩的冷冻保存/自动转移
选项。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Exogenous insulin-like growth factor 1 accelerates growth and maturation of follicles in human cortical xenografts and increases ovarian output in mice.
- DOI:10.1016/j.xfss.2021.07.002
- 发表时间:2021-08
- 期刊:
- 影响因子:0
- 作者:Man, Limor;Lustgarten Guahmich, Nicole;Kallinos, Eleni;Park, Laura;Caiazza, Barbara;Khan, Monica;Liu, Zong-Ying;Patel, Ritaben;Torres, Carmen;Lekovich, Jovana;Zhong, Liangwen;Bodine, Richard;Wen, Duancheng;Zaninovic, Nikica;Schattman, Glenn;Rosenwaks, Zev;James, Daylon
- 通讯作者:James, Daylon
Xenograft model of heterotopic transplantation of human ovarian cortical tissue and its clinical relevance.
- DOI:10.1530/rep-22-0114
- 发表时间:2023-01-01
- 期刊:
- 影响因子:3.8
- 作者:Man, Limor;Lustgarten Guahmich, Nicole;Kallinos, Eleni;Park, Laura;Bodine, Richard;Zaninovic, Nikica;Schattman, Glenn;Rosenwaks, Zev;James, Daylon
- 通讯作者:James, Daylon
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daylon J James其他文献
Daylon J James的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daylon J James', 18)}}的其他基金
Anti-Mullerian hormone for preserving ovarian function before administration of gonadotoxic therapies or after transplantation of cryopreserved tissue.
抗苗勒氏管激素,用于在性腺毒性治疗前或冷冻组织移植后保留卵巢功能。
- 批准号:
10719540 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别:
Optimized protocols for ovarian tissue cryopreservation and novel modRNA-based approaches to improve transplantation outcomes for fertility preservation in chronically diseased girls
卵巢组织冷冻保存的优化方案和基于 modRNA 的新型方法可改善慢性病女孩生育力保存的移植结果
- 批准号:
10303952 - 财政年份:2021
- 资助金额:
$ 25.93万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms of Juvenile Neurogenesis and Post-Stroke Recovery: Determining the Role of Age-Associated Neuroimmune Interactions
青少年神经发生和中风后恢复的机制:确定与年龄相关的神经免疫相互作用的作用
- 批准号:
10637874 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别:
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
感染和未感染艾滋病毒的幼儿结核感染的进展:PROTECT 研究
- 批准号:
10641389 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别:
A Novel VpreB1 Anti-body Drug Conjugate for the Treatment of B-Lineage Acute Lymphoblastic Leukemia/Lymphoma
一种用于治疗 B 系急性淋巴细胞白血病/淋巴瘤的新型 VpreB1 抗体药物偶联物
- 批准号:
10651082 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别:
Feasibility of a care team-focused action plan to improve quality of care for children and adolescents with inflammatory bowel disease
以护理团队为重点的行动计划的可行性,以提高炎症性肠病儿童和青少年的护理质量
- 批准号:
10724900 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别:
The Impact of Early Life Stress On Amygdala Circuitry And Chronic Excessive Aggression
早期生活压力对杏仁核回路和慢性过度攻击性的影响
- 批准号:
10729031 - 财政年份:2023
- 资助金额:
$ 25.93万 - 项目类别: